Leukocyte activation after coronary stenting in patients during the subacute phase of a previous ST-elevation

Dimitrios A Stakos1, Ioannis Kotsianidis, Dimitrios N Tziakas

  • 1Cardiology Department, Democritus University of Thrace, Alexandroupolis, and 2nd Cardiology Department, Papanikolaou General Hospital, Thessaloniki, Greece. dstakos@med.duth.gr

Coronary Artery Disease
|February 16, 2007
PubMed

Insights

Leukocyte activation, specifically CD62L expression, reliably indicates early changes after percutaneous coronary intervention in ST-elevation myocardial infarction patients. This cellular biomarker may predict future events or restenosis.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Interventional Cardiology

Background:

  • ST-elevation myocardial infarction (STEMI) requires interventions like percutaneous coronary intervention (PCI).
  • Leukocyte activation is a key factor in cardiovascular events post-PCI.
  • Understanding early cellular responses is crucial for risk stratification.

Purpose of the Study:

  • To investigate leukocyte activation markers following PCI in STEMI patients.
  • To assess changes in neutrophil and monocyte activation.
  • To identify early cellular biomarkers of PCI-induced inflammation.

Main Methods:

  • Flow cytometry assessed CD11b and CD62L expression on neutrophils and monocytes.
  • Measurements were taken before and after coronary angiography and PCI.
  • Plasma cytokines and C-reactive protein levels were also monitored.

Main Results:

  • CD11b expression significantly increased post-PCI and coronary angiography, with a greater increase after PCI.
  • CD62L expression decreased significantly after PCI but not after coronary angiography.
  • No significant changes were observed in plasma cytokine or C-reactive protein levels.

Conclusions:

  • CD62L is a specific and reliable early biomarker of leukocyte activation post-PCI in STEMI patients.
  • Further research is needed to determine if CD62L predicts future events or restenosis.
  • This finding aids in understanding the inflammatory response to PCI.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Inflammation II: Cellular Phase01:26

Acute Inflammation II: Cellular Phase

The cellular phase of acute inflammation is a tightly orchestrated sequence of events that recruits leukocytes, primarily neutrophils, to sites of tissue injury or infection. Following the initial vascular changes, this phase ensures effective immune cell migration, activation, and function at the affected site to eliminate pathogens and initiate tissue repair.Leukocyte Recruitment CascadeLeukocyte recruitment happens in four steps: margination, adhesion, transmigration, and chemotaxis. Reduced...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...